Prognostic Value of Angiographic Microcirculatory Resistance After Coronary Intervention: Insights From the FAVOR III China Trial

Cardiovascular Risk and Diseases

The prognostic value of systemic inflammatory response index (SIRI) in acute coronary syndrome patients treated with primary percutaneous coronary intervention: a meta-analysis and systematic review

Clin Res Cardiol

Hu C, Ye Q, You S, Li S, Dostal C, Ernst M, Paneni F, Pokreisz P, Szabo GT, Kiss A, Podesser BK

doi: 10.1007/s00392-026-02889-4

Heart, Artery and Coronary Diseases

Prognostic Value of Plaque Volume in Patients With First Diagnosis of Coronary Artery Disease: A Substudy of the PROMISE Randomized Clinical Trial

JAMA Cardiol

Karády J, Mayrhofer T, Brendel JM, Kolossváry M, Langenbach M, Langenbach I, Baliyan V, Sturniolo AK, Pagidipati N, Lu MT, Ferencik M, Shah S, Douglas PS, Foldyna B

doi: 10.1001/jamacardio.2025.5520

Heart, Artery and Coronary Diseases

Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial

Eur Heart J

Dillinger JG, Pezel T, Batias L, Angoulvant D, Goralski M, Ferrari E, Cayla G, Silvain J, Gilard M, Lemesle G, Souteyrand G, Lim P, Roubille F, Georges JL, Bal Dit Sollier C, Petroni T, Morel O, Delarche N, Elbaz M, Puymirat E, Toupin S, Montalescot G, Drouet L, Vicaut E, Henry P, ANDAMAN Investigators of the ACTION Study Group

doi: 10.1093/eurheartj/ehaf680

Heart, Artery and Coronary DiseasesTherapy and Intervention

Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial

Lancet

Delewi R, Aarts HM, Broeze GM, Hemelrijk KI, van Ginkel DJ, Versteeg GAA, Grundeken MJ, Claessen BEPM, Tonino PAL, Schotborgh CE, Meuwissen M, van Houwelingen GK, Wykrzykowska JJ, Amoroso G, Vossenberg TN, Vriesendorp PA, van Royen N, Ten Berg JM, Tijssen JGP, Voskuil M, PRO-TAVI trial investigators

doi: 10.1016/S0140-6736(26)00308-9

Heart, Artery and Coronary DiseasesMyocardial InfarctionTherapy and Intervention

Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: Design of the AMUNDSEN Trial

Am Heart J

Montalescot G, Bolognese L, Bartus S, Cequier-Fillat A, Thiele H, Mach F, Jukema JW, Ferrari E, Souteyrand G, Bouleti C, Range G, Chioccioli M, Picchi A, Batias-Moreau L, Esposito G, Braik N, Redjimi N, Duband B, Guedeney P, Zeitouni M, Brochard K, Silvain J, Vicaut E, AMUNDSEN investigators of the ACTION Study Group

doi: 10.1016/j.ahj.2025.107295

Heart, Artery and Coronary DiseasesTherapy and Intervention

OCT vs Angiography for Guidance of Percutaneous Coronary Intervention of Calcified Lesions: The CALIPSO Randomized Clinical Trial

JAMA Cardiol

Amabile N, Rangé G, Landolff Q, Bressollette E, Meneveau N, Lattuca B, Levesque S, Boueri Z, Adjedj J, Casassus F, Belfekih A, Veugeois A, Souteyrand G, Honton B

doi: 10.1001/jamacardio.2025.0741

Heart, Artery and Coronary Diseases

Technical use of intravascular ultrasound in chronic total occlusion percutaneous coronary interventions: insights from the Euro-CTO registry

Clin Res Cardiol

Arioti M, Moroni A, Mashayekhi K, Werner GS, Agostoni P, Gorgulu S, Ayoub M, Avran A, Kalay N, Goktekin O, Ladwiniec A, Zaczkiewicz M, Wojcik J, Arenz J, Rathore S, Atmowihardjo I, Dalibor J, Christiansen EH, Chico LG, Gasparini GL, Galassi AR, Vadalà G, Gagnor A, Diletti R, Behnes M, Pyxaras SA, Di Mario C, Boudou N, Garbo R

doi: 10.1007/s00392-025-02788-0

Further Publications

Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis: Insights From the EVOLVED Randomized Clinical Trial

JAMA Cardiol

Craig NJ, Loganath K, Everett RJ, Bing R, Ramtoola T, Tsampasian V, Molek P, Botezatu S, Aslam S, MacGillivray T, Tuck CE, Rayson P, Calvert PA, Berry C, Chin CWL, Hillis GS, Fairbairn T, Greenwood JP, Steeds R, Leslie SJ, Lang CC, Bucciarelli-Ducci C, Joshi NV, Kunadian V, Prendergast B, Mills NL, Vassiliou VS, Dungu JN, Hothi SS, Boon N, Prasad SK, Keenan NG, Dawson D, Motwani M, Miller CA, Rajani R, Ripley DP, Treibel TA, McCann GP, Singh A, Newby DE, Dweck MR, EVOLVED investigators

doi: 10.1001/jamacardio.2026.0654

Heart, Artery and Coronary Diseases

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial

Lancet

Kang J, Park S, Yang HM, Shin ES, Rha SW, Bae JW, Lee NH, Yoon HJ, Cho YH, Kim U, Kim SY, Kim SH, Han JK, Park KW, Kim HS, HOST-EXAM investigators

doi: 10.1016/S0140-6736(26)00422-8

Related content

The prognostic value of systemic inflammatory response index (SIRI) in acute coronary syndrome patients treated with primary percutaneous coronary intervention: a meta-analysis and systematic review

Prognostic Value of Plaque Volume in Patients With First Diagnosis of Coronary Artery Disease: A Substudy of the PROMISE Randomized Clinical Trial

Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial

Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial

Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: Design of the AMUNDSEN Trial

OCT vs Angiography for Guidance of Percutaneous Coronary Intervention of Calcified Lesions: The CALIPSO Randomized Clinical Trial

Technical use of intravascular ultrasound in chronic total occlusion percutaneous coronary interventions: insights from the Euro-CTO registry

Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis: Insights From the EVOLVED Randomized Clinical Trial

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial